Disclosures for "Sex and Gender Differences Influence Urinary Symptoms and Management in Multiple System Atrophy")
-
Dr. Schipani Bailey has nothing to disclose.
-
Ms. Hooshmand has nothing to disclose.
-
Negin Badihian has nothing to disclose.
-
Dr. Sandroni has nothing to disclose.
-
Dr. Benarroch has nothing to disclose.
-
The institution of Dr. Bower has received research support from Abbvie.
-
Dr. Low has nothing to disclose.
-
Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Icon PLC. The institution of Dr. Singer has received research support from NIH. Dr. Singer has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Coon has nothing to disclose.